 | • レポートコード：20QY06-08478 • 出版社/出版日：QYResearch / 2020年6月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、140ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医療機器 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、埋め込み型薬剤溶出デバイスのグローバル市場について種類別（埋め込み型薬剤注入ポンプ、眼内薬剤溶出装置、避妊薬溶出装置、薬剤溶出ステント、その他）、用途別（糖尿病、避妊、HIV/AIDS予防、慢性疼痛管理、循環器、眼科、腫瘍学、その他）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・埋め込み型薬剤溶出デバイス市場の概要 ・世界の主要地域別埋め込み型薬剤溶出デバイス市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の埋め込み型薬剤溶出デバイス市場規模2015-2026：種類別（埋め込み型薬剤注入ポンプ、眼内薬剤溶出装置、避妊薬溶出装置、薬剤溶出ステント、その他） ・世界の埋め込み型薬剤溶出デバイス市場規模2015-2026：用途別（糖尿病、避妊、HIV/AIDS予防、慢性疼痛管理、循環器、眼科、腫瘍学、その他） ・埋め込み型薬剤溶出デバイスの北米市場規模2015-2020 ・埋め込み型薬剤溶出デバイスのヨーロッパ市場規模2015-2020 ・埋め込み型薬剤溶出デバイスの中国市場規模2015-2020 ・埋め込み型薬剤溶出デバイスの日本市場規模2015-2020 ・埋め込み型薬剤溶出デバイスの東南アジア市場規模2015-2020 ・埋め込み型薬剤溶出デバイスのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Pfizer、Medtronic、Merck、Bayer AG、Johnson & Johnson、Abbott、Surmodics、Boston Scientific Corporation、Titan Pharmaceuticals, Inc.、BIOTRONIK、Allergan、Bausch & Lomb、REVA Medical、MicroPort Medical） ・埋め込み型薬剤溶出デバイスの製造コスト分析 ・販売チャネル、流通業者、顧客 ・埋め込み型薬剤溶出デバイスの市場動向・機会・課題 ・調査の結論 |
A recently published report by QY Research titled Global Implantable Drug-Eluting Devices Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Implantable Drug-Eluting Devices market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Implantable drug-eluting devices offer several unique advantages over conventional oral or parenteral drug delivery methods.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Implantable Drug-Eluting Devices market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Implantable Drug-Eluting Devices industry.
Based on our recent survey, we have several different scenarios about the Implantable Drug-Eluting Devices YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Implantable Drug-Eluting Devices will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Implantable Drug-Eluting Devices market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Implantable Drug-Eluting Devices market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Implantable Drug-Eluting Devices market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Implantable Drug-Eluting Devices market. The report also includes nautical information, where it shows Implantable Drug-Eluting Devices market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Implantable Drug-Eluting Devices market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Implantable Drug-Eluting Devices market.
Geographical Analysis:
Based on region, the global Implantable Drug-Eluting Devices market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Implantable Drug-Eluting Devices market are
Pfizer
Medtronic
Merck
Bayer AG
Johnson & Johnson
Abbott
Surmodics
Boston Scientific Corporation
Titan Pharmaceuticals, Inc.
BIOTRONIK
Allergan
Bausch & Lomb
REVA Medical
MicroPort Medical
Segment by Type
Implantable Drug Infusion Pumps
Intraocular Drug-Eluting Devices
Contraceptive Drug-Eluting Devices
Drug-Eluting Stents
Others
Segment by Application
Diabetes
Contraception
HIV/AIDS Prevention
Chronic Pain Management
Cardiovascular
Ophthalmology
Oncology
Others
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Implantable Drug-Eluting Devices market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Implantable Drug-Eluting Devices market.
• The market share of the global Implantable Drug-Eluting Devices market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Implantable Drug-Eluting Devices market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Implantable Drug-Eluting Devices market.
1 Implantable Drug-Eluting Devices Market Overview
1.1 Implantable Drug-Eluting Devices Product Scope
1.2 Implantable Drug-Eluting Devices Segment by Type
1.2.1 Global Implantable Drug-Eluting Devices Sales by Type (2020-2026)
1.2.2 Implantable Drug Infusion Pumps
1.2.3 Intraocular Drug-Eluting Devices
1.2.4 Contraceptive Drug-Eluting Devices
1.2.5 Drug-Eluting Stents
1.2.6 Others
1.3 Implantable Drug-Eluting Devices Segment by Application
1.3.1 Global Implantable Drug-Eluting Devices Sales Comparison by Application (2020-2026)
1.3.2 Diabetes
1.3.3 Contraception
1.3.4 HIV/AIDS Prevention
1.3.5 Chronic Pain Management
1.3.6 Cardiovascular
1.3.7 Ophthalmology
1.3.8 Oncology
1.3.9 Others
1.4 Implantable Drug-Eluting Devices Market Estimates and Forecasts (2015-2026)
1.4.1 Global Implantable Drug-Eluting Devices Sales Growth Rate (2015-2026)
1.4.2 Global Implantable Drug-Eluting Devices Revenue and Growth Rate (2015-2026)
1.4.3 Global Implantable Drug-Eluting Devices Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Implantable Drug-Eluting Devices Industry Impact
1.5.1 How the Covid-19 is Affecting the Implantable Drug-Eluting Devices Industry
1.5.1.1 Implantable Drug-Eluting Devices Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Implantable Drug-Eluting Devices Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Implantable Drug-Eluting Devices Players to Combat Covid-19 Impact
2 Implantable Drug-Eluting Devices Estimate and Forecast by Region
2.1 Global Implantable Drug-Eluting Devices Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Implantable Drug-Eluting Devices Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Implantable Drug-Eluting Devices Sales Market Share by Region (2015-2020)
2.2.2 Global Implantable Drug-Eluting Devices Revenue Market Share by Region (2015-2020)
2.3 Global Implantable Drug-Eluting Devices Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Implantable Drug-Eluting Devices Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Implantable Drug-Eluting Devices Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Implantable Drug-Eluting Devices Estimates and Projections (2015-2026)
2.4.2 Europe Implantable Drug-Eluting Devices Estimates and Projections (2015-2026)
2.4.3 China Implantable Drug-Eluting Devices Estimates and Projections (2015-2026)
2.4.4 Japan Implantable Drug-Eluting Devices Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Implantable Drug-Eluting Devices Estimates and Projections (2015-2026)
2.4.6 India Implantable Drug-Eluting Devices Estimates and Projections (2015-2026)
3 Global Implantable Drug-Eluting Devices Competition Landscape by Players
3.1 Global Top Implantable Drug-Eluting Devices Players by Sales (2015-2020)
3.2 Global Top Implantable Drug-Eluting Devices Players by Revenue (2015-2020)
3.3 Global Implantable Drug-Eluting Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Implantable Drug-Eluting Devices as of 2019)
3.4 Global Implantable Drug-Eluting Devices Average Price by Company (2015-2020)
3.5 Manufacturers Implantable Drug-Eluting Devices Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Implantable Drug-Eluting Devices Players (Opinion Leaders)
4 Global Implantable Drug-Eluting Devices Market Size by Type
4.1 Global Implantable Drug-Eluting Devices Historic Market Review by Type (2015-2020)
4.1.1 Global Implantable Drug-Eluting Devices Sales Market Share by Type (2015-2020)
4.1.2 Global Implantable Drug-Eluting Devices Revenue Market Share by Type (2015-2020)
4.1.3 Global Implantable Drug-Eluting Devices Price by Type (2014-2020)
4.2 Global Implantable Drug-Eluting Devices Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Implantable Drug-Eluting Devices Sales Forecast by Type (2021-2026)
4.2.2 Global Implantable Drug-Eluting Devices Revenue Forecast by Type (2021-2026)
4.2.3 Global Implantable Drug-Eluting Devices Price Forecast by Type (2021-2026)
5 Global Implantable Drug-Eluting Devices Market Size by Application
5.1 Global Implantable Drug-Eluting Devices Historic Market Review by Application (2015-2020)
5.1.1 Global Implantable Drug-Eluting Devices Sales Market Share by Application (2015-2020)
5.1.2 Global Implantable Drug-Eluting Devices Revenue Market Share by Application (2015-2020)
5.1.3 Global Implantable Drug-Eluting Devices Price by Application (2015-2020)
5.2 Global Implantable Drug-Eluting Devices Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Implantable Drug-Eluting Devices Sales Forecast by Application (2021-2026)
5.2.2 Global Implantable Drug-Eluting Devices Revenue Forecast by Application (2021-2026)
5.2.3 Global Implantable Drug-Eluting Devices Price Forecast by Application (2021-2026)
3 North America Implantable Drug-Eluting Devices Market Facts & Figures
3.2 North America Implantable Drug-Eluting Devices Sales Market Share by Company (2015-2020)
3.3 North America Implantable Drug-Eluting Devices Sales Market Share by Type (2015-2020)
3.4 North America Implantable Drug-Eluting Devices Sales Market Share by Application (2015-2020)
4 Europe Implantable Drug-Eluting Devices Market Facts & Figures
4.2 Europe Implantable Drug-Eluting Devices Sales Market Share by Company (2015-2020)
4.3 Europe Implantable Drug-Eluting Devices Sales Market Share by Type (2015-2020)
4.4 Europe Implantable Drug-Eluting Devices Sales Market Share by Application (2015-2020)
5 China Implantable Drug-Eluting Devices Market Facts & Figures
5.2 China Implantable Drug-Eluting Devices Sales Market Share by Company (2015-2020)
5.3 China Implantable Drug-Eluting Devices Sales Market Share by Type (2015-2020)
5.4 China Implantable Drug-Eluting Devices Sales Market Share by Application (2015-2020)
6 Japan Implantable Drug-Eluting Devices Market Facts & Figures
6.2 Japan Implantable Drug-Eluting Devices Sales Market Share by Company (2015-2020)
6.3 Japan Implantable Drug-Eluting Devices Sales Market Share by Type (2015-2020)
6.4 Japan Implantable Drug-Eluting Devices Sales Market Share by Application (2015-2020)
7 Southeast Asia Implantable Drug-Eluting Devices Market Facts & Figures
7.2 Southeast Asia Implantable Drug-Eluting Devices Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Implantable Drug-Eluting Devices Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Implantable Drug-Eluting Devices Sales Market Share by Application (2015-2020)
8 India Implantable Drug-Eluting Devices Market Facts & Figures
8.2 India Implantable Drug-Eluting Devices Sales Market Share by Company (2015-2020)
8.3 India Implantable Drug-Eluting Devices Sales Market Share by Type (2015-2020)
8.4 India Implantable Drug-Eluting Devices Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Implantable Drug-Eluting Devices Business
12.1 Pfizer
12.1.1 Pfizer Implantable Drug-Eluting Devices Corporation Information
12.1.2 Pfizer Implantable Drug-Eluting Devices Business Overview and Total Revenue
12.1.3 Pfizer Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Pfizer Implantable Drug-Eluting Devices Products Offered
12.1.5 Pfizer Recent Development
12.2 Medtronic
12.2.1 Medtronic Implantable Drug-Eluting Devices Corporation Information
12.2.2 Medtronic Implantable Drug-Eluting Devices Business Overview and Total Revenue
12.2.3 Medtronic Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Medtronic Implantable Drug-Eluting Devices Products Offered
12.2.5 Medtronic Recent Development
12.3 Merck
12.3.1 Merck Implantable Drug-Eluting Devices Corporation Information
12.3.2 Merck Implantable Drug-Eluting Devices Business Overview and Total Revenue
12.3.3 Merck Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Merck Implantable Drug-Eluting Devices Products Offered
12.3.5 Merck Recent Development
12.4 Bayer AG
12.4.1 Bayer AG Implantable Drug-Eluting Devices Corporation Information
12.4.2 Bayer AG Implantable Drug-Eluting Devices Business Overview and Total Revenue
12.4.3 Bayer AG Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Bayer AG Implantable Drug-Eluting Devices Products Offered
12.4.5 Bayer AG Recent Development
12.5 Johnson & Johnson
12.5.1 Johnson & Johnson Implantable Drug-Eluting Devices Corporation Information
12.5.2 Johnson & Johnson Implantable Drug-Eluting Devices Business Overview and Total Revenue
12.5.3 Johnson & Johnson Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Johnson & Johnson Implantable Drug-Eluting Devices Products Offered
12.5.5 Johnson & Johnson Recent Development
12.6 Abbott
12.6.1 Abbott Implantable Drug-Eluting Devices Corporation Information
12.6.2 Abbott Implantable Drug-Eluting Devices Business Overview and Total Revenue
12.6.3 Abbott Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Abbott Implantable Drug-Eluting Devices Products Offered
12.6.5 Abbott Recent Development
12.7 Surmodics
12.7.1 Surmodics Implantable Drug-Eluting Devices Corporation Information
12.7.2 Surmodics Implantable Drug-Eluting Devices Business Overview and Total Revenue
12.7.3 Surmodics Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Surmodics Implantable Drug-Eluting Devices Products Offered
12.7.5 Surmodics Recent Development
12.8 Boston Scientific Corporation
12.8.1 Boston Scientific Corporation Implantable Drug-Eluting Devices Corporation Information
12.8.2 Boston Scientific Corporation Implantable Drug-Eluting Devices Business Overview and Total Revenue
12.8.3 Boston Scientific Corporation Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Boston Scientific Corporation Implantable Drug-Eluting Devices Products Offered
12.8.5 Boston Scientific Corporation Recent Development
12.9 Titan Pharmaceuticals, Inc.
12.9.1 Titan Pharmaceuticals, Inc. Implantable Drug-Eluting Devices Corporation Information
12.9.2 Titan Pharmaceuticals, Inc. Implantable Drug-Eluting Devices Business Overview and Total Revenue
12.9.3 Titan Pharmaceuticals, Inc. Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Titan Pharmaceuticals, Inc. Implantable Drug-Eluting Devices Products Offered
12.9.5 Titan Pharmaceuticals, Inc. Recent Development
12.10 BIOTRONIK
12.10.1 BIOTRONIK Implantable Drug-Eluting Devices Corporation Information
12.10.2 BIOTRONIK Implantable Drug-Eluting Devices Business Overview and Total Revenue
12.10.3 BIOTRONIK Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2015-2020)
12.10.4 BIOTRONIK Implantable Drug-Eluting Devices Products Offered
12.10.5 BIOTRONIK Recent Development
12.11 Allergan
12.11.1 Allergan Implantable Drug-Eluting Devices Corporation Information
12.11.2 Allergan Implantable Drug-Eluting Devices Business Overview and Total Revenue
12.11.3 Allergan Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Allergan Implantable Drug-Eluting Devices Products Offered
12.11.5 Allergan Recent Development
12.12 Bausch & Lomb
12.12.1 Bausch & Lomb Implantable Drug-Eluting Devices Corporation Information
12.12.2 Bausch & Lomb Implantable Drug-Eluting Devices Business Overview and Total Revenue
12.12.3 Bausch & Lomb Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Bausch & Lomb Implantable Drug-Eluting Devices Products Offered
12.12.5 Bausch & Lomb Recent Development
12.13 REVA Medical
12.13.1 REVA Medical Implantable Drug-Eluting Devices Corporation Information
12.13.2 REVA Medical Implantable Drug-Eluting Devices Business Overview and Total Revenue
12.13.3 REVA Medical Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2015-2020)
12.13.4 REVA Medical Implantable Drug-Eluting Devices Products Offered
12.13.5 REVA Medical Recent Development
12.14 MicroPort Medical
12.14.1 MicroPort Medical Implantable Drug-Eluting Devices Corporation Information
12.14.2 MicroPort Medical Implantable Drug-Eluting Devices Business Overview and Total Revenue
12.14.3 MicroPort Medical Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2015-2020)
12.14.4 MicroPort Medical Implantable Drug-Eluting Devices Products Offered
12.14.5 MicroPort Medical Recent Development
13 Implantable Drug-Eluting Devices Manufacturing Cost Analysis
13.1 Implantable Drug-Eluting Devices Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Implantable Drug-Eluting Devices
13.4 Implantable Drug-Eluting Devices Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Implantable Drug-Eluting Devices Distributors List
14.3 Implantable Drug-Eluting Devices Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Implantable Drug-Eluting Devices Sales (K Units) Growth Rate by Type (2020-2026)
Table 2. Global Implantable Drug-Eluting Devices Sales (K Units) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Implantable Drug-Eluting Devices Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Implantable Drug-Eluting Devices Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Implantable Drug-Eluting Devices Players to Combat Covid-19 Impact
Table 8. Global Market Implantable Drug-Eluting Devices Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Implantable Drug-Eluting Devices Sales (K Units) by Region (2015-2020)
Table 10. Global Implantable Drug-Eluting Devices Sales Market Share by Region (2015-2020)
Table 11. Global Implantable Drug-Eluting Devices Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Implantable Drug-Eluting Devices Revenue Share by Region (2015-2020)
Table 13. Global Implantable Drug-Eluting Devices Sales (K Units) Forecast by Region (2021-2026)
Table 14. Global Implantable Drug-Eluting Devices Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Implantable Drug-Eluting Devices Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Implantable Drug-Eluting Devices Revenue Share Forecast by Region (2021-2026)
Table 17. Global Implantable Drug-Eluting Devices (K Units) of Key Companies (2015-2020)
Table 18. Global Implantable Drug-Eluting Devices Sales Share by Company (2015-2020)
Table 19. Global Implantable Drug-Eluting Devices Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Implantable Drug-Eluting Devices Revenue Share by Company (2015-2020)
Table 21. Global Implantable Drug-Eluting Devices by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Implantable Drug-Eluting Devices as of 2019)
Table 22. Global Implantable Drug-Eluting Devices Average Price (USD/Unit) of Key Company (2015-2020)
Table 23. Manufacturers Implantable Drug-Eluting Devices Manufacturing Sites and Area Served
Table 24. Manufacturers Implantable Drug-Eluting Devices Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Implantable Drug-Eluting Devices Players
Table 27. Global Implantable Drug-Eluting Devices Sales (K Units) by Type (2015-2020)
Table 28. Global Implantable Drug-Eluting Devices Sales Share by Type (2015-2020)
Table 29. Global Implantable Drug-Eluting Devices Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Implantable Drug-Eluting Devices Price (K Units) by Type (2015-2020)
Table 31. Global Implantable Drug-Eluting Devices Sales Share by Type (2021-2026)
Table 32. Global Implantable Drug-Eluting Devices Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Implantable Drug-Eluting Devices Revenue Share by Type (2021-2026)
Table 34. Global Implantable Drug-Eluting Devices Price (K Units) by Type (2021-2026)
Table 35. Global Implantable Drug-Eluting Devices Sales (K Units) by Application (2015-2020)
Table 36. Global Implantable Drug-Eluting Devices Sales Share by Application (2015-2020)
Table 37. Global Implantable Drug-Eluting Devices Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Implantable Drug-Eluting Devices Price (K Units) by Application (2015-2020)
Table 39. Global Implantable Drug-Eluting Devices Sales (K Units) by Application (2021-2026)
Table 40. Global Implantable Drug-Eluting Devices Sales Share by Application (2021-2026)
Table 41. Global Implantable Drug-Eluting Devices Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Implantable Drug-Eluting Devices Revenue Share by Application (2021-2026)
Table 43. Global Implantable Drug-Eluting Devices Price (K Units) by Application (2021-2026)
Table 44. United States Implantable Drug-Eluting Devices Sales (K Units) by Company (2015-2020)
Table 45. United States Implantable Drug-Eluting Devices Sales Market Share by Company (2015-2020)
Table 46. United States Implantable Drug-Eluting Devices Sales (K Units) by Type (2015-2020)
Table 47. United States Implantable Drug-Eluting Devices Sales Market Share by Type (2015-2020)
Table 48. United States Implantable Drug-Eluting Devices Sales (K Units) by Application (2015-2020)
Table 49. United States Implantable Drug-Eluting Devices Sales Market Share by Application (2015-2020)
Table 50. Europe Implantable Drug-Eluting Devices Sales (K Units) by Company (2015-2020)
Table 51. Europe Implantable Drug-Eluting Devices Sales Market Share by Company (2015-2020)
Table 52. Europe Implantable Drug-Eluting Devices Sales (K Units) by Type (2015-2020)
Table 53. Europe Implantable Drug-Eluting Devices Sales Market Share by Type (2015-2020)
Table 54. Europe Implantable Drug-Eluting Devices Sales (K Units) by Application (2015-2020)
Table 55. Europe Implantable Drug-Eluting Devices Sales Market Share by Type (2015-2020)
Table 56. China Implantable Drug-Eluting Devices Sales (K Units) by Company (2015-2020)
Table 57. China Implantable Drug-Eluting Devices Sales Market Share by Company (2015-2020)
Table 58. China Implantable Drug-Eluting Devices Sales (K Units) by Type (2015-2020)
Table 59. China Implantable Drug-Eluting Devices Sales Market Share by Type (2015-2020)
Table 60. China Implantable Drug-Eluting Devices Sales (K Units) by Application (2015-2020)
Table 61. China Implantable Drug-Eluting Devices Sales Market Share by Application (2015-2020)
Table 62. Japan Implantable Drug-Eluting Devices Sales (K Units) by Company (2015-2020)
Table 63. Japan Implantable Drug-Eluting Devices Sales Market Share by Company (2015-2020)
Table 64. Japan Implantable Drug-Eluting Devices Sales (K Units) by Type (2015-2020)
Table 65. Japan Implantable Drug-Eluting Devices Sales Market Share by Type (2015-2020)
Table 66. Japan Implantable Drug-Eluting Devices Sales (K Units) by Application (2015-2020)
Table 67. Japan Implantable Drug-Eluting Devices Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Implantable Drug-Eluting Devices Sales (K Units) by Company (2015-2020)
Table 69. Southeast Asia Implantable Drug-Eluting Devices Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Implantable Drug-Eluting Devices Sales (K Units) by Type (2015-2020)
Table 71. Southeast Asia Implantable Drug-Eluting Devices Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Implantable Drug-Eluting Devices Sales (K Units) by Type (2015-2020)
Table 73. Southeast Asia Implantable Drug-Eluting Devices Sales Market Share by Application (2015-2020)
Table 74. India Implantable Drug-Eluting Devices Sales (K Units) by Company (2015-2020)
Table 75. India Implantable Drug-Eluting Devices Sales Market Share by Company (2015-2020)
Table 76. India Implantable Drug-Eluting Devices Sales (K Units) by Type (2015-2020)
Table 77. India Implantable Drug-Eluting Devices Sales Market Share by Type (2015-2020)
Table 78. India Implantable Drug-Eluting Devices Sales (K Units) by Application (2015-2020)
Table 79. India Implantable Drug-Eluting Devices Sales Market Share by Application (2015-2020)
Table 80. Pfizer Corporation Information
Table 81. Pfizer Description and Business Overview
Table 82. Pfizer Implantable Drug-Eluting Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Pfizer Implantable Drug-Eluting Devices Product
Table 84. Pfizer Recent Development
Table 85. Medtronic Corporation Information
Table 86. Medtronic Description and Business Overview
Table 87. Medtronic Implantable Drug-Eluting Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Medtronic Implantable Drug-Eluting Devices Product
Table 89. Medtronic Recent Development
Table 90. Merck Corporation Information
Table 91. Merck Description and Business Overview
Table 92. Merck Implantable Drug-Eluting Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Merck Implantable Drug-Eluting Devices Product
Table 94. Merck Recent Development
Table 95. Bayer AG Corporation Information
Table 96. Bayer AG Description and Business Overview
Table 97. Bayer AG Implantable Drug-Eluting Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Bayer AG Implantable Drug-Eluting Devices Product
Table 99. Bayer AG Recent Development
Table 100. Johnson & Johnson Corporation Information
Table 101. Johnson & Johnson Description and Business Overview
Table 102. Johnson & Johnson Implantable Drug-Eluting Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Johnson & Johnson Implantable Drug-Eluting Devices Product
Table 104. Johnson & Johnson Recent Development
Table 105. Abbott Corporation Information
Table 106. Abbott Description and Business Overview
Table 107. Abbott Implantable Drug-Eluting Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Abbott Implantable Drug-Eluting Devices Product
Table 109. Abbott Recent Development
Table 110. Surmodics Corporation Information
Table 111. Surmodics Description and Business Overview
Table 112. Surmodics Implantable Drug-Eluting Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Surmodics Implantable Drug-Eluting Devices Product
Table 114. Surmodics Recent Development
Table 115. Boston Scientific Corporation Corporation Information
Table 116. Boston Scientific Corporation Implantable Drug-Eluting Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Boston Scientific Corporation Description and Business Overview
Table 118. Boston Scientific Corporation Implantable Drug-Eluting Devices Product
Table 119. Boston Scientific Corporation Recent Development
Table 120. Titan Pharmaceuticals, Inc. Corporation Information
Table 121. Titan Pharmaceuticals, Inc. Implantable Drug-Eluting Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. Titan Pharmaceuticals, Inc. Description and Business Overview
Table 123. Titan Pharmaceuticals, Inc. Implantable Drug-Eluting Devices Product
Table 124. Titan Pharmaceuticals, Inc. Recent Development
Table 125. BIOTRONIK Corporation Information
Table 126. BIOTRONIK Description and Business Overview
Table 127. BIOTRONIK Implantable Drug-Eluting Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. BIOTRONIK Implantable Drug-Eluting Devices Product
Table 129. BIOTRONIK Recent Development
Table 130. Allergan Corporation Information
Table 131. Allergan Description and Business Overview
Table 132. Allergan Implantable Drug-Eluting Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 133. Allergan Implantable Drug-Eluting Devices Product
Table 134. Allergan Recent Development
Table 135. Bausch & Lomb Corporation Information
Table 136. Bausch & Lomb Description and Business Overview
Table 137. Bausch & Lomb Implantable Drug-Eluting Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 138. Bausch & Lomb Implantable Drug-Eluting Devices Product
Table 139. Bausch & Lomb Recent Development
Table 140. REVA Medical Corporation Information
Table 141. REVA Medical Description and Business Overview
Table 142. REVA Medical Implantable Drug-Eluting Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 143. REVA Medical Implantable Drug-Eluting Devices Product
Table 144. REVA Medical Recent Development
Table . MicroPort Medical Corporation Information
Table . MicroPort Medical Description and Business Overview
Table . MicroPort Medical Implantable Drug-Eluting Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table . MicroPort Medical Implantable Drug-Eluting Devices Product
Table . MicroPort Medical Recent Development
Table 150. Production Base and Market Concentration Rate of Raw Material
Table 151. Key Suppliers of Raw Materials
Table 152. Implantable Drug-Eluting Devices Distributors List
Table 153. Implantable Drug-Eluting Devices Customers List
Table 154. Market Key Trends
Table 155. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 156. Key Challenges
Table 157. Research Programs/Design for This Report
Table 158. Key Data Information from Secondary Sources
Table 159. Key Data Information from Primary Sources
List of Figures
Figure 1. Implantable Drug-Eluting Devices Product Picture
Figure 2. Global Implantable Drug-Eluting Devices Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Implantable Drug-Eluting Devices Market Share by Application in 2020 & 2026
Figure 6. Diabetes Examples
Figure 7. Contraception Examples
Figure 8. HIV/AIDS Prevention Examples
Figure 9. Chronic Pain Management Examples
Figure 10. Cardiovascular Examples
Figure 11. Ophthalmology Examples
Figure 12. Oncology Examples
Figure 13. Others Examples
Figure 14. Global Implantable Drug-Eluting Devices Sales (K Units) Growth Rate (2015-2026)
Figure 15. Global Implantable Drug-Eluting Devices Revenue (US$ Million) Growth Rate (2015-2026)
Figure 16. Global Implantable Drug-Eluting Devices Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 17. Global Implantable Drug-Eluting Devices Revenue Market Share by Region: 2015 VS 2020
Figure 18. Global Implantable Drug-Eluting Devices Revenue Market Share by Region: 2021 VS 2026
Figure 19. United States Implantable Drug-Eluting Devices Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. United States Implantable Drug-Eluting Devices Sales (K Units) Growth Rate (2015-2026)
Figure 21. Europe Implantable Drug-Eluting Devices Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Europe Implantable Drug-Eluting Devices Sales (Million USD) Growth Rate (2015-2026)
Figure 23. China Implantable Drug-Eluting Devices Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. China Implantable Drug-Eluting Devices Sales (Million USD) and Growth Rate (2015-2026)
Figure 25. Japan Implantable Drug-Eluting Devices Revenue (Million USD) Growth Rate (2015-2026)
Figure 26. Japan Implantable Drug-Eluting Devices Sales (Million USD) Growth Rate (2015-2026)
Figure 27. Southeast Asia Implantable Drug-Eluting Devices Revenue (Million USD) Growth Rate (2015-2026)
Figure 28. Southeast Asia Implantable Drug-Eluting Devices Sales (Million USD) Growth Rate (2015-2026)
Figure 29. India Implantable Drug-Eluting Devices Revenue (Million USD) Growth Rate (2015-2026)
Figure 30. India Implantable Drug-Eluting Devices Sales (Million USD) Growth Rate (2015-2026)
Figure 31. Global 5 Largest Implantable Drug-Eluting Devices Players Market Share by Revenue in Implantable Drug-Eluting Devices 2015 & 2019
Figure 32. Implantable Drug-Eluting Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 33. Global Implantable Drug-Eluting Devices Revenue Share by Type (2015-2020)
Figure 34. Global Implantable Drug-Eluting Devices Revenue Growth Rate by Type in 2015 & 2019
Figure 35. Global Implantable Drug-Eluting Devices Revenue Share by Application (2015-2020)
Figure 36. Global Implantable Drug-Eluting Devices Revenue Growth Rate by Application in 2015 & 2019
Figure 37. United States Implantable Drug-Eluting Devices Sales Market Share by Type in 2019
Figure 38. United States Implantable Drug-Eluting Devices Sales Market Share by Type in 2019
Figure 39. Europe Implantable Drug-Eluting Devices Sales Market Share by Company in 2019
Figure 40. Europe Implantable Drug-Eluting Devices Sales Market Share by Type in 2019
Figure 41. Europe Implantable Drug-Eluting Devices Sales Market Share by Application in 2019
Figure 42. China Implantable Drug-Eluting Devices Sales Market Share by Company in 2019
Figure 43. China Implantable Drug-Eluting Devices Sales Market Share by Type in 2019
Figure 44. China Implantable Drug-Eluting Devices Sales Market Share by Application in 2019
Figure 45. Japan Implantable Drug-Eluting Devices Sales Market Share by Company in 2019
Figure 46. Japan Implantable Drug-Eluting Devices Sales Market Share by Type in 2019
Figure 47. Japan Implantable Drug-Eluting Devices Sales Market Share by Application in 2019
Figure 48. Southeast Asia Implantable Drug-Eluting Devices Sales Market Share by Company in 2019
Figure 49. Southeast Asia Implantable Drug-Eluting Devices Sales Market Share by Type in 2019
Figure 50. Southeast Asia Implantable Drug-Eluting Devices Sales Market Share by Application in 2019
Figure 51. India Implantable Drug-Eluting Devices Sales Market Share by Company in 2019
Figure 52. India Implantable Drug-Eluting Devices Sales Market Share by Type in 2019
Figure 53. India Implantable Drug-Eluting Devices Sales Market Share by Application in 2019
Figure 54. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Medtronic Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Bayer AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Abbott Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Surmodics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Boston Scientific Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Titan Pharmaceuticals, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. BIOTRONIK Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. Allergan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 65. Bausch & Lomb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 66. REVA Medical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 67. MicroPort Medical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 68. Key Raw Materials Price Trend
Figure 69. Manufacturing Cost Structure of Implantable Drug-Eluting Devices
Figure 70. Manufacturing Process Analysis of Implantable Drug-Eluting Devices
Figure 71. Implantable Drug-Eluting Devices Industrial Chain Analysis
Figure 72. Channels of Distribution
Figure 73. Distributors Profiles
Figure 74. Porter's Five Forces Analysis
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed
埋め込み型心臓デバイスの世界市場レポート2020 Market Analysis and Insights: Global Implantable Cardiac Devices Market The global Implantable Cardiac Devices market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Implantable Cardiac Devices Scope and Market …- 植込み型心臓デバイスの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Implantable Cardiac Devices market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Implantable Cardi…
- 注射可能型ドラッグデリバリーデバイスの世界市場レポート2020 Injectable drug delivery devices are the devices used to administer drugs into the circulatory system. It is the most effective and common route for the administration of most therapeutic agents to ensure a quick response. Injectable drugs are used when patient is unconscious and require quick effec…
- アクティブ埋め込み型医療機器の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Active Implantable Medical Devices market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 7.2% in the forecast period of 2020 to 2025 and will expected to reach USD 20220 million by 2025, from USD 15330 million in 2019. The Act…
- ドラッグデリバリーデバイスの世界市場レポート2020 Drug delivery devices are used to delivery drug to the specific part of body or cure some disease. With the help of drug delivery devices, drug can efficiently reach the target and be in a controlled manner. Generally, there are several of drug delivery devices corresponding to the medicine taken wa…